Molecular Approaches To Antiviral Development For Viral Hepatitis and Other Viral Diseases — T. Jake Liang (NATIONAL INSTITUTE OF
Therapy for hepatitis C virus (HCV) infection has advanced rapidly with the recent approval of several direct-acting antivirals. However, most of the DAAs in clinical use or clinical trials target the
| Project title | Molecular Approaches To Antiviral Development For Viral Hepatitis and Other Viral Diseases |
|---|---|
| Project number | 1ZIADK054503-27 |
| PI name | T. Jake Liang |
| Institution | NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES |
| Funding mechanism | ZIA |
| Agency | NIDDK |
| Award amount | $2.20M |
| Fiscal year | 2023 |
| Abstract | Therapy for hepatitis C virus (HCV) infection has advanced rapidly with the recent approval of several direct-acting antivirals. However, most of the DAAs in clinical use or clinical trials target the |
| Key terms | <2019 novel corona virus><2019 novel coronavirus><2019-nCoV><Affect><Antiviral Agents><Antiviral Dru |
$799/mo
Try GrantRadar →